Monica Walker, MD
Family Medicine · Riviera Beach, FLNPI 1003950551
Payments from drug & device makers
Across 214 payments — averaging $24.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$836
- Lilly USA, LLC$573
- Novo Nordisk$499
- Pfizer$434
- Vanda Pharmaceuticals Inc.$374
- Paratek Pharmaceuticals, Inc.$365
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,29299%
- Education$511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 31 | $836 |
| Lilly USA, LLC | 23 | $573 |
| Novo Nordisk | 19 | $499 |
| Pfizer | 15 | $434 |
| Vanda Pharmaceuticals Inc. | 13 | $374 |
| Paratek Pharmaceuticals, Inc. | 34 | $365 |
| Atricure, Inc. | 2 | $272 |
| Boehringer Ingelheim | 7 | $235 |
| ANI Pharmaceuticals, Inc. | 12 | $200 |
| Amarin Pharma, Inc. | 6 | $197 |
| GSK | 9 | $166 |
| Johnson & Johnson(2 entities) | 6 | $157 |
| Silk Road Medical, Inc. | 1 | $152 |
| Amgen | 7 | $138 |
| Abbott | 5 | $108 |
| Edwards Lifesciences | 1 | $105 |
| Exactech, Inc. | 1 | $100 |
| Arbor Pharmaceuticals, Inc. | 4 | $65 |
| Redhill Biopharma Inc. | 4 | $65 |
| Dexcom, Inc. | 3 | $61 |
| Kowa Pharmaceuticals America, Inc. | 2 | $42 |
| AbbVie(2 entities) | 2 | $41 |
| Exact Sciences | 1 | $33 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$272
- ENROUTE Transcarotid Neuroprotection System$152
- ENROUTE Transcarotid Stent System$152
- ENHANCE Transcarotid Peripheral Access Kit$152
- ENROUTE 0.014 Guidewire$152
- SYNERGY ABLATION SYSTEM$136
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$136
- ATRICLIP LAA EXCLUSION SYSTEM$136
- Vascepa$125
- ZEPBOUND$125
- AIRSUPRA$125
- JARDIANCE$118
- FARXIGA$117
- Xultophy 100/3.6$114
- EUCRISA$108
- Edwards SAPIEN 3 Transcatheter Heart Valve$105
- Ozempic$101
- NOVATION HIP$100
How this compares
$5,343 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 53 | $77,604 |
| OzempicSemaglutide | 71 | $67,722 |
| EliquisApixaban | 41 | $41,577 |
| FarxigaDapagliflozin Propanediol | 29 | $31,891 |
| XareltoRivaroxaban | 36 | $29,263 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,755 |
| Atorvastatin Calcium | 336 | $4,460 |
| Valsartan | 101 | $3,109 |
| Novolog FlexpenInsulin Aspart | 18 | $2,933 |
| Nifedipine ErNifedipine | 68 | $2,630 |
| Losartan Potassium | 203 | $2,184 |
| Gabapentin | 118 | $2,171 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 12 | $2,050 |
| LantusInsulin Glargine,hum.Rec.Anlog | 21 | $1,878 |
| Montelukast Sodium | 154 | $1,552 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $235 | $77,60453 claims |
| Novo NordiskOzempic | $499 | $67,72271 claims |
| PfizerEliquis | $434 | $41,57741 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $836 | $40,64743 claims |
| Johnson & JohnsonXarelto | $157 | $29,26336 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $200 | $3,109101 claims |
| Sanofi-aventis U.S. LLCLantus | $15 | $1,87821 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $29 | $81762 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Riviera Beach
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.